Stock listing

Creo Medical Group Plc

Selected listing: A2DH40 · LS · EUR · DE

Creo Medical Group Plc (Lang & Schwarz: A2DH40), Health Technology. Latest release Sep 30, 2026: Unaudited interim results.

A2DH40:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A2DH40
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Lang & Schwarz
Currency: EUR

About Creo Medical Group Plc

The company focuses on developing advanced medical devices that utilize innovative technologies for minimally invasive surgical procedures. Creo Medical aims to improve patient outcomes and enhance the efficiency of healthcare delivery through its cutting-edge solutions.

Latest news from Creo Medical Group Plc

Unaudited interim results

September 30, 2026

H1-26 Trading Update

July 28, 2026

MicroBlate™ Flex exceeds 100 clinical cases

July 23, 2026

Appointment of Nominated Adviser /Corporate Broker

June 23, 2026

Posting of 2025 Annual Report and Notice of AGM

June 4, 2026

All Creo Medical Group Plc news →

Events

Replays

CREO MEDICAL GROUP PLC (CREO) — Interim results for the six months ended 30 June 2025
Wed, Sep 24, 2025 · 11:00 AM ET
Watch
CREO MEDICAL GROUP PLC (CREO) — Preliminary results for the year ended 31 December 2024
Mon, May 19, 2025 · 06:30 AM ET
Watch
CREO MEDICAL GROUP PLC (CREO) — Full Year Results
Wed, May 15, 2024 · 10:00 AM ET
Watch

Research Creo Medical Group Plc

Creo Medical Group Plc company profile

View the public company page for Creo Medical Group Plc on 6ix.

Creo Medical Group Plc news

Read company news and market updates connected to Creo Medical Group Plc.

Creo Medical Group Plc investor events

Find investor webinars, events, and replay context for Creo Medical Group Plc.